Vir Biotechnology VIR
NASDAQ VIR
$13.03 -0.11 (-0.87%)
As of: Nov 11, 2026 · 10:45 AM EST

Vir Biotechnology (VIR) Net Equity Issued and Repurchased (2018 - 2026)

Updated

Vir Biotechnology (VIR) posted Net Equity Issued and Repurchased of $1.63 million for Q3 2026, compared with $101,000 a year earlier.

Analysis

Vir Biotechnology (VIR) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Net Equity Issued and Repurchased at Vir Biotechnology was $5.65 million, up 29.6% year-over-year; for FY2025, it came in at $4.15 million, down 8.9% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -58.3% (FY2020 to FY2025).
  • In prior years, Vir Biotechnology's Net Equity Issued and Repurchased was $4.55 million in FY2024 (-41.4%), $7.77 million in FY2023 (+0.1%), $7.76 million in FY2022 (-49.6%) and $15.38 million in FY2021 (-95.3%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of -$159.55 million in Q2 2026 to a high of $162.52 million in Q1 2026 over five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last five quarters, with growth averaging 29.4%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q1 2023, with growth of 377.3%; the weakest was Q1 2024, with a decline of 90.4%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was -$159.55 million (Q2 2026), $162.52 million (Q1 2026) and $1.04 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vir Biotechnology 2.23 Bn 313.19 Mn 188,000.00 1.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.63 Mn
Jun 30, 2026 -159.55 Mn
Mar 31, 2026 162.52 Mn
Dec 31, 2025 1.04 Mn
Sep 30, 2025 101,000.00
Jun 30, 2025 2.41 Mn
Mar 31, 2025 598,000.00
Dec 31, 2024 1.25 Mn
Sep 30, 2024 71,000.00
Jun 30, 2024 3.01 Mn
Mar 31, 2024 221,000.00
Dec 31, 2023 1.77 Mn
Sep 30, 2023 343,000.00
Jun 30, 2023 3.35 Mn
Mar 31, 2023 2.31 Mn
Dec 31, 2022 2.09 Mn
Sep 30, 2022 2.04 Mn
Jun 30, 2022 3.14 Mn
Mar 31, 2022 484,000.00
Dec 31, 2021 5.74 Mn
API Access

Vir Biotechnology Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VIR&period=max&api_key=YOUR_API_KEY